tbuckley/cabot-search huggingface dataset:
Flavanols from the Camellia sinensis var. assamica and their hypoglycemic and hypolipidemic activities
Authors: Xin Wang, Quan Liu, Hongbo Zhu, Hongqing Wang, Jie Kang, Zhufang Shen, Ruoyun Chen
Journal: Acta Pharmaceutica Sinica B (2017)

α-Glucosidase and lipase inhibitors play important roles in the treatment of hyperglycaemia and dyslipidemia. To identify novel naturally occurring inhibitors, a bioactivity-guided phytochemical research was performed on the pu-erh tea. One new flavanol, named (-)-epicatechin-3-O-(Z)-coumarate (1), and 16 known analogs (2-17) were isolated from the aqueous extract of the pu-erh tea. Their structures were determined by spectroscopic and chemical methods. Furthermore, the water extract of pu-erh tea and its fractions exhibited inhibitory activities against α-glucosidases and lipases in vitro; compound 15 showed moderate inhibitory effect against sucrase with an IC50 value of 32.5 μmol/L and significant inhibitory effect against maltase with an IC50 value of 1.3 μmol/L. Compounds 8, 10, 11 and 15 displayed moderate activity against a lipase with IC50 values of 16.0, 13.6, 19.8, and 13.3 μmol/L, respectively.
Pancreatic enzyme replacement therapy in chronic pancreatitis: a long way to go
Authors: John A Windsor
Journal: Gut (2017)

Pancreatic exocrine insufficiency (PEI) in chronic pancreatitis (CP) is underdiagnosed and undertreated. An important and expertly conducted meta-analysis in this issue examines the efficacy of pancreatic enzyme replacement therapy (PERT) in patients with CP.1 The key findings are that PERT increases fat and protein absorption and does so more effectively with higher dosing, enteric coating, administration with food and concomitant acid suppression. The follow-up studies indicated that PERT increases serum nutritional parameters, improves GI symptoms and quality of life without significant adverse events. While none of these findings are new, the study provides a higher level of evidence for them.

The meta-analysis is important for several other reasons. First, only level 1 evidence is used (n=14 randomised controlled trials) for the quantitative analysis of fat absorption. Second, it counters the inconclusive Cochrane Review2 and should remove any lingering doubt about the efficacy of PERT in CP. Third, it is confined to CP and does not complicate things by attempting to address the more challenging questions about the role of PERT in other pancreatic diseases, after pancreatic …
A phase II study of single-agent gemtuzumab ozogamicin in relapsed/refractory pediatric acute myeloid leukemia (AML)
Authors: C. M. Zwaan, D. Reinhardt, M. Zimmermann, U. Creutzig, G. J. L. Kaspers
Journal: Journal of Clinical Oncology (2005)

8524 Background: GO consists of an anti-CD33 antibody linked to the cytotoxic compound calicheamicin, and is licensed for use in elderly patients (pts.) with AML. In children the maxiumum tolerated dose (MTD) is 2x7.5mg/m2, with a 14-day interval. We previously reported significant activity of GO (compassionate use treatment with variable dosages) in heavily pretreated children with AML (Blood 2003). Methods: We here report on a multi-center phase II study in children with 2nd relapse or refractory AML. Only pts. treated for 1st relapse according to the Relapsed AML 2001/01 study, which randomizes FLAG ± liposomal daunorubicin for re-induction, were eligible. GO was administered at MTD-level. Responding pts. could either be offered additional GO courses or be transplanted. Results: So far, 20 pts. (13 refractory; 7 second relapses) were enrolled with evaluable data on safety and response. Two pts. had been transplanted prior to GO. Median age was 8.2 years, WBC 5.6x10.9/l. Eleven pts. were not eligible and considered study pts (SP). The number of GO infusion was: 1, n=5; 2, n=11; 5, n=2; 6, n=1; 7, n=1. The response rate was 40% (defined as CR or CRp), and did not differ between refractory and relapsed pts. Median survival of responding pts. was 1.04 years vs. 0.39 years in non-responders (p=0.43). Leukemic cell CD33-positivity varied from 47–100% (median 84%), but did not correlate with response. After a grade 4 infusion-related hypotension in a SP an amendment for prophylaxis with methylpred. 1 mg/kg was issued. In another pt. a grade 4 hypotension 8 hrs. after GO infusion occurred, due to a cytokine release syndrome. Other grade 3–4 adverse events consisted of hematological toxicity in >90%, infection in 38% and nausea in 18% of pts. Grade 3–4 transaminase/bilirubin elevation occurred only in 1 pt. Six responding pts. were transplanted following GO-reinduction of which one developed sinusoidal obstruction syndrome. Conclusions: GO is active as single agent in children with relapsed/refractory AML, with manageable toxicity. Further studies in newly diagnosed pediatric AML using either single-agent GO in consolidation, or GO in combination chemotherapy in induction, are ongoing. No significant financial relationships to disclose.
Instructing Human Macrophage Polarization by Stiffness and Glycosaminoglycan Functionalization in 3D Collagen Networks
Authors: Markus Friedemann, Liv Kalbitzer, Sandra Franz, Stephanie Moeller, Matthias Schnabelrauch, Jan‐Christoph Simon, Tilo Pompe, Katja Franke
Journal: Advanced Healthcare Materials (2017)

Dynamic alterations of composition and mechanics of the extracellular matrix are suggested to modulate cellular behavior including plasticity of macrophages (MPhs) during wound healing. In this study, engineered 3D fibrillar matrices based on naturally occurring biopolymers (collagen I, glycosaminoglycans (GAGs)) are used to mimic matrix stiffening as well as modification by sulfated and nonsulfated GAGs at different stages of wound healing. Human MPhs are found to sensitively respond to these microenvironmental cues in terms of polarization toward proinflammatory or wound healing phenotypes over 6 days in vitro. MPhs exhibit a wound healing phenotype in stiffer matrices as determined by protein and gene expression of relevant cytokines (IL10, IL12, and TNFα). Presence of sulfated and nonsulfated GAGs inhibits this polarization effect. Furthermore, control experiments on 2D matrices stress the relevance of using stiffness-controlled 3D matrices, as MPhs show a reciprocal polarization behavior depending on GAG presence. Hence, the results indicate a strong influence of dimensionality, stiffness, and GAG presence of the biomaterial scaffold on MPh polarization and emphasize the need for matrices closely mimicking the 3D in vivo context with a variable stiffness and GAG composition in in vitro studies.
Deciphering the Critical Pathways of Mutant N-RAS in AML Using Small Molecule Inhibitors.
Authors: Atsushi Nonami, Martin Sattler, Ellen L. Weisberg, Liu Qingsong, Jianming Zhang, Guillaume Adelmant, Jarrod A Marto, Nancy Kohl, Andrew L. Kung, Taebo Sim, Nathanael S Gray, James D. Griffin
Journal: Blood (2012)
Improved Outcome in Unrelated Donor Recipients After Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Advanced Relapse / Refractory Chronic Lymphocytic Leukemia
Authors: Januario E. Castro, Juan S. Barajas-Gamboa, Julio A. Diaz-Perez, Lina M. Ariza-Serrano, Sue Corringham, Thomas J. Kipps, Edward D. Ball
Journal: Blood (2011)
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone (PCRM): A New Highly Active Regimen for Patients with Chronic Lymphocytic Leukemia (CLL) Previously Treated with PCR or FCR.
Authors: Nicole Lamanna, Mark L. Heaney, Renier J. Brentjens, Joseph G. Jurcic, Mark A. Weiss
Journal: Blood (2007)
HGAL, a Lymphoma Prognostic Biomarker, Regulates Lymphocyte and Lymphoma Cell Motility by Modulation of RhoA Signaling Pathway.
Authors: Xiaoyu Jiang, Xiaoqing Lu, George Mcnamara, Xiaofei Liu, Kristopher A Sarosiek, David M. Helfman, Izidore S Lossos
Journal: Blood (2009)
Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.
Authors: Michal Sieniawski, Andreas Josting, Carmen Canals, Anthony H. Goldstone, Martin Gramatzki, Didier Blaise, Christian Gisselbrecht, Charles Crawley, Philippe Colombat, Jean-Luc Harousseau, Peter Johnson, Angelo Michele Carella, Anna Sureda, Gerard Socie, Norbert Schmitz
Journal: Blood (2007)
Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.
Authors: Branimir Jaksic, Ozren Jaksic, Mirjana M. Kardum-Paro, Ika Kardum-Skelin
Journal: Blood (2005)
Clinical and pathologic factors associated with subclinical spread of invasive melanoma
Authors: Thuzar M. Shin, Waqas R. Shaikh, Jeremy R. Etzkorn, Joseph F. Sobanko, David J. Margolis, Joel M. Gelfand, Emily Y. Chu, Rosalie Elenitsas, Christopher J. Miller
Journal: Journal of the American Academy of Dermatology (2017)
The WD40-Repeats of Ahi-1 Oncogene Critical for Protein Interaction Between Ahi-1 and BCR-ABL Modulates Imatinib-Induced Apoptosis In BCR-ABL-Transduced Cells
Authors: Min Chen, Leon Zhou, Matthew Chan, Damian Lai, Ali G. Turhan, Ralph B. Arlinghaus, Xiaoyan Jiang
Journal: Blood (2010)
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502
Authors: Steven M. Devine, Kouros Owzar, William Blum, Daniel DeAngelo, Richard M. Stone, Jack W Hsu, Richard E. Champlin, Yi-Bin A. Chen, Ravi Vij, James L Slack, Robert J. Soiffer, Richard A. Larson, Thomas C. Shea, Vera Hars, Elizabeth Bennett, Sada Spangle, Sergio A Giralt, Shelly L. Carter, Mary M. Horowitz, Charles Linker, Edwin P Alyea
Journal: Blood (2012)
Effect of Thalidomide and Arsenic Trioxide On the Release of Tumor Necrosis Factor – α (TNF-α) and Vascular Endothelial Growth Factor (VEGF) From the KG-1a Human Acute Myelogenous Leukemia Cell Line.
Authors: Erian Girgis, John Mahoney, Rafaat Khalil, Magdi Soliman
Journal: Blood (2009)
Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy
Authors: Kyle Wang, Michael J. Eblan, Allison M. Deal, Matthew Lipner, Timothy M. Zagar, Yue Wang, Panayiotis Mavroidis, Carrie B. Lee, Brian C. Jensen, Julian G. Rosenman, Mark A. Socinski, Thomas E. Stinchcombe, Lawrence B. Marks
Journal: Journal of Clinical Oncology (2017)

Purpose The significance of radiotherapy (RT) -associated cardiac injury for stage III non-small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with worse overall survival in the Radiation Therapy Oncology Group (RTOG) 0617 study. We assessed the impact of heart dose in patients treated at our institution on several prospective dose-escalation trials. Patients and Methods From 1996 to 2009, 127 patients with stage III NSCLC (Eastern Cooperative Oncology Group performance status, 0 to 1) received dose-escalated RT to 70 to 90 Gy (median, 74 Gy) in six trials. RT plans and cardiac doses were reviewed. Records were reviewed for the primary end point: symptomatic cardiac events (symptomatic pericardial effusion, acute coronary syndrome, pericarditis, significant arrhythmia, and heart failure). Cardiac risk was assessed by noting baseline coronary artery disease and calculating the WHO/International Society of Hypertension score. Competing risks analysis was used. Results In all, 112 patients were analyzed. Median follow-up for surviving patients was 8.8 years. Twenty-six patients (23%) had one or more events at a median of 26 months to first event (effusion [n = 7], myocardial infarction [n = 5], unstable angina [n = 3], pericarditis [n = 2], arrhythmia [n = 12], and heart failure [n = 1]). Heart doses (eg, heart mean dose; hazard ratio, 1.03/Gy; P = .002,), coronary artery disease ( P < .001), and WHO/International Society of Hypertension score ( P = .04) were associated with events on univariable analysis. Heart doses remained significant on multivariable analysis that accounted for baseline risk. Two-year competing risk-adjusted event rates for patients with heart mean dose < 10 Gy, 10 to 20 Gy, or ≥ 20 Gy were 4%, 7%, and 21%, respectively. Heart doses were not associated with overall survival. Conclusion Cardiac events were relatively common after high-dose thoracic RT and were independently associated with both heart dose and baseline cardiac risk. RT-associated cardiac toxicity after treatment of stage III NSCLC may occur earlier than historically understood, and heart doses should be minimized.
Who Decides? The Autonomy of First Respondents in Initiating Out-of-Hospital CPR
Authors: Sabine Salloch
Journal: The American Journal of Bioethics (2017)

Rosoff and Schneiderman (2017) discuss empirical and societal aspects of out-of-hospital cardiopulmonary resuscitation (OHCPR) convincingly as a highly important ethical issue that is the subject o...
What Can the Use of Anesthesia Services for Endoscopy in the Veterans Health Administration Teach Us About Appropriate Care?
Authors: Lee A. Fleisher
Journal: JAMA Internal Medicine (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
Most surgical patients do not need anti-clotting drugs, analysis finds
Authors: Jacqui Wise
Journal: BMJ (2017)

Three quarters of surgical patients may be receiving anticoagulants that they do not need, a meta-analysis published in the Annals of Surgery has found.1

Current guidelines recommend that surgical patients are given chemoprophylaxis to prevent deep vein thrombosis and pulmonary embolisms. However, researchers say that this is necessary in only around 25% of surgical patients—those at the highest risk, with a Caprini score of 7 or above.

Christopher Pannucci, study leader and assistant professor of surgery at the University of Utah in Salt Lake City, USA, said, “A ‘one-size-fits-all approach’ doesn’t always make sense. A healthy …
Benefit-Risk Assessments at the US Food and Drug Administration
Authors: Robert M. Califf
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Long Term Efficacy and Safety of Cladribine In Adult Systemic mastocytosis: a French Multicenter Study of 44 Patients
Authors: Olivier Hermine, Isabelle Hirsh, Gandhi Damaj, Catherine Granpeix, Stéphane Barète, Felipe Suarez, Olivia Chansderis, David Ghez, Richard Delarue, Fanny Lanternier, Benedicte Deau, Helene Coignard, Sylvie Fraitag, Danielle Canioni, Philippe Casassus, Patrice Dubreuil, Olivier Lortholary
Journal: Blood (2010)
Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model
Authors: Assaf Lask, Eran Ophir, Noga Or-Geva, Adva Cohen, Ran Afik, Yaki Eidelstein, Robert Negrin, Arnon Nagler, Alain Berrebi, David Hagin, Yair Reisner
Journal: Blood (2010)
Alternative inert gas washout outcomes in patients with primary ciliary dyskinesia
Authors: Sylvia Nyilas, Anne Schlegtendal, Florian Singer, Myrofora Goutaki, Claudia E. Kuehni, Carmen Casaulta, Philipp Latzin, Cordula Koerner-Rettberg
Journal: European Respiratory Journal (2017)

The lung clearance index (LCI) derived from a nitrogen multiple breath washout test (N 2 -MBW) is a promising tool to assess small airways disease in primary ciliary dyskinesia, but it is difficult to apply in routine clinical settings because of its long measuring time. In this study, we aimed to assess alternative indices derived from shorter washout protocols. 49 patients with primary ciliary dyskinesia (mean age 14.7±6.6 years) and 37 controls (mean age 14.3±1.4 years) performed N 2 -MBW and double-tracer gas (DTG) single-breath washout tests. Global (LCI and moment ratio (M 2 /M 0 )), conductive ( S cond ) and acinar ventilation inhomogeneity (DTG Slope III (S III -DTG)) were determined for each individual. The main outcomes were 1) the ability to detect abnormal lung function from washout indices (&gt;1.64 z-scores) and 2) measurement duration. The prevalence of abnormal values for LCI 2.5% was 37 out of 47 (79%), for LCI 5% was 34 out of 47 (72%), for M 2 /M 0 was 34 out of 47 (72%), for S cond was 36 out of 46 (78%) and for S III -DTG was 12 out of 35 (34%). Mean± sd duration of measurement was 19.8±11.2 min for LCI 2.5% , 10.8±4.6 min for LCI 5% and 8.6±2.3 min for S cond . Compared to standard LCI 2.5% , ventilation inhomogeneity was detected by LCI 5% , moment ratio and S cond with comparable sensitivity while measurement duration was significantly shorter. Longitudinal studies will show which outcome is most suitable and practical in terms of sensitivity, duration and variability within the course of primary ciliary dyskinesia lung disease.
AVL-292, a Bruton's Tyrosine Kinase Inhibitor Impacts Bone Resorption by Abrogating Osteoclast Sealing Zone Formation in Multiple Myeloma
Authors: Homare Eda, Loredana Santo, Diana Cirstea, Andrew J. Yee, Anuj Mahindra, Tyler Scullen, Neeharika Nemani, Yuko Mishima, Erica Evans, Juswinder Singh, Wes Westlin, Noopur Raje
Journal: Blood (2012)
Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease
Authors: Elizabeth Parks, Hannele Yki-Järvinen, Meredith Hawkins
Journal: Journal of Clinical Investigation (2017)

Nonalcoholic fatty liver disease (NAFLD) is characterized by excess accumulation of fat in the liver. In some cases, NAFLD is also accompanied by insulin resistance, resulting in metabolic dysfunction. Dietary fat content probably influences both NAFLD and insulin resistance; however, the immediate effects of fat consumption have not been fully explored. In this issue of the JCI, Hernández et al. evaluated hepatic glucose and lipid metabolism in humans and mice following a single oral dose of saturated fat. This one bolus of fat resulted in a measurable increase in insulin resistance, hepatic triglycerides, and gluconeogenesis. In mice, the saturated fat bolus resulted in the induction of several NAFLD-associated genes. Together, the results of this study indicate that saturated fat intake has immediate effects on metabolic function.
Inkjet‐Printed PEDOT:PSS Electrodes on Paper for Electrocardiography
Authors: Eloïse Bihar, Timothée Roberts, Mohamed Saadaoui, Thierry Hervé, Jozina B. De Graaf, George G. Malliaras
Journal: Advanced Healthcare Materials (2017)

Inkjet-printed PEDOT:PSS electrodes are shown to record cutaneous electrophysiological signals such as electrocardiograms via a simple finger-to-electrode contact. The recordings are of high quality and show no deterioration over a 3 month period, paving the way for the development of the next generation of low-cost, convenient-to-use healthcare monitoring devices. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Diabetes Drug Gains New Indication
Authors: Rebecca Voelker
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid–Induced Hepatic Sinusoidal Obstruction Syndrome
Authors: Xin Li, Xiaoqian Yang, Dong Xu, Qian Li, Xiangchuang Kong, Zhiwen Lu, Tao Bai, Keshu Xu, Jin Ye, Yuhu Song
Journal: Clinical Gastroenterology and Hepatology (2017)
Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Authors: Michel van Gelder, Dimitris Ziagkos, Liesbeth C de Wreede, Anja van Biezen, Peter Dreger, Martin Gramatzki, Matthias Stelljes, Niels Smedegaard Andersen, Nicolaas PM Schaap, Antonin Vitek, Dietrich Beelen, Liisa Volin, Jürgen Finke, Jakob R Passweg, Arnold Ganser, Maciej J Machaczka, Julio Delgado, William Krüger, Edgar Faber, Gerard Socie, Pavel Jindra, Boris V Afanasyev, Matthias Theobald, Yves Chalandon, Anja Henseler, Stefan O. Schoenland, Kroger Nicolaus, Johannes Schetelig
Journal: Blood (2016)